Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
De Leo S, D'Elia S, Grani G, Dondi F, Bertagna F, Puxeddu E, Morelli S, Piovesan A, Nervo A, Zatelli MC, Gagliardi I, Samà MT, Aimaretti G, Crocetti U, Massa M, Deandrea M, Retta F, Pagano L, Rossi M, Solaroli E, Pezzullo L, Chiofalo MG, Pontecorvi A, Lombardi CP, Antonelli A, Patrizio A, Messuti I, Magri F, Spiazzi G, Ceresini G, Bruno R, Sparano C, Centanni M, Crescenzi A, Tallini G, Marotta V, Madeo B, Mian C, Filetti S, Durante C, Fugazzola L. De Leo S, et al. Among authors: marotta v. Thyroid. 2023 Nov;33(11):1318-1326. doi: 10.1089/thy.2023.0052. Epub 2023 Oct 19. Thyroid. 2023. PMID: 37725571
High growth rate of benign thyroid nodules bearing RET/PTC rearrangements.
Sapio MR, Guerra A, Marotta V, Campanile E, Formisano R, Deandrea M, Motta M, Limone PP, Fenzi G, Rossi G, Vitale M. Sapio MR, et al. Among authors: marotta v. J Clin Endocrinol Metab. 2011 Jun;96(6):E916-9. doi: 10.1210/jc.2010-1599. Epub 2011 Mar 16. J Clin Endocrinol Metab. 2011. PMID: 21411555
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
Marotta V, Franzese MD, Del Prete M, Chiofalo MG, Ramundo V, Esposito R, Marciello F, Pezzullo L, Carratù A, Vitale M, Colao A, Faggiano A. Marotta V, et al. Expert Opin Pharmacother. 2013 Jun;14(9):1187-203. doi: 10.1517/14656566.2013.796931. Expert Opin Pharmacother. 2013. PMID: 23675883 Review.
Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A. Marotta V, et al. J Clin Endocrinol Metab. 2017 Feb 1;102(2):661-671. doi: 10.1210/jc.2016-2555. J Clin Endocrinol Metab. 2017. PMID: 27849428
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A. Marotta V, et al. Endocrine. 2017 Sep;57(3):539-543. doi: 10.1007/s12020-016-1200-6. Epub 2016 Dec 16. Endocrine. 2017. PMID: 27981515 No abstract available.
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A. Marotta V, et al. Endocrine. 2017 Sep;57(3):544. doi: 10.1007/s12020-017-1269-6. Endocrine. 2017. PMID: 28243971 No abstract available.
68 results